121 related articles for article (PubMed ID: 32875624)
1. Efficient estimation of human immunodeficiency virus incidence rate using a pooled cross-sectional cohort study design.
Molebatsi K; Gabaitiri L; Mokgatlhe L; Moyo S; Gaseitsiwe S; Wirth KE; DeGruttola V; Tchetgen Tchetgen E
Stat Med; 2020 Oct; 39(24):3255-3271. PubMed ID: 32875624
[TBL] [Abstract][Full Text] [Related]
2. Cross-sectional human immunodeficiency virus incidence estimation accounting for heterogeneity across communities.
Xu Y; Laeyendecker O; Wang R
Biometrics; 2019 Sep; 75(3):1017-1028. PubMed ID: 30746695
[TBL] [Abstract][Full Text] [Related]
3. The AIDS epidemic in India: a new method for estimating current human immunodeficiency virus (HIV) incidence rates.
Brookmeyer R; Quinn T; Shepherd M; Mehendale S; Rodrigues J; Bollinger R
Am J Epidemiol; 1995 Oct; 142(7):709-13. PubMed ID: 7572940
[TBL] [Abstract][Full Text] [Related]
4. Estimating HIV incidence from age-specific prevalence data: comparison with concurrent cohort estimates in a study of male factory workers, Harare, Zimbabwe.
Gregson S; Machekano R; Donnelly CA; Mbizvo MT; Anderson RM; Katzenstein DA
AIDS; 1998 Oct; 12(15):2049-58. PubMed ID: 9814874
[TBL] [Abstract][Full Text] [Related]
5. Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations.
Kirkpatrick AR; Patel EU; Celum CL; Moore RD; Blankson JN; Mehta SH; Kirk GD; Margolick JB; Quinn TC; Eshleman SH; Laeyendecker O
AIDS Res Hum Retroviruses; 2016 Aug; 32(8):756-62. PubMed ID: 26988426
[TBL] [Abstract][Full Text] [Related]
6. Double Robust Efficient Estimators of Longitudinal Treatment Effects: Comparative Performance in Simulations and a Case Study.
Tran L; Yiannoutsos C; Wools-Kaloustian K; Siika A; van der Laan M; Petersen M
Int J Biostat; 2019 Feb; 15(2):. PubMed ID: 30811344
[TBL] [Abstract][Full Text] [Related]
7. Antibody avidity-based approach to estimate population-level incidence of hepatitis C.
Boon D; Bruce V; Patel EU; Quinn J; Srikrishnan AK; Shanmugam S; Iqbal S; Balakrishnan P; Sievers M; Kirk GD; Thomas DL; Quinn TC; Cox AL; Page KA; Solomon SS; Mehta SH; Laeyendecker O
J Hepatol; 2020 Aug; 73(2):294-302. PubMed ID: 32240715
[TBL] [Abstract][Full Text] [Related]
8. HIV incidence determination in the United States: a multiassay approach.
Laeyendecker O; Brookmeyer R; Cousins MM; Mullis CE; Konikoff J; Donnell D; Celum C; Buchbinder SP; Seage GR; Kirk GD; Mehta SH; Astemborski J; Jacobson LP; Margolick JB; Brown J; Quinn TC; Eshleman SH
J Infect Dis; 2013 Jan; 207(2):232-9. PubMed ID: 23129760
[TBL] [Abstract][Full Text] [Related]
9. Augmented cross-sectional studies with abbreviated follow-up for estimating HIV incidence.
Claggett B; Lagakos SW; Wang R
Biometrics; 2012 Mar; 68(1):62-74. PubMed ID: 21668904
[TBL] [Abstract][Full Text] [Related]
10. Mixture models for calibrating the BED for HIV incidence testing.
Mahiane SG; Fiamma A; Auvert B
Stat Med; 2014 May; 33(10):1767-83. PubMed ID: 24834521
[TBL] [Abstract][Full Text] [Related]
11. Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests.
Brookmeyer R; Quinn TC
Am J Epidemiol; 1995 Jan; 141(2):166-72. PubMed ID: 7817972
[TBL] [Abstract][Full Text] [Related]
12. Augmented cross-sectional prevalence testing for estimating HIV incidence.
Wang R; Lagakos SW
Biometrics; 2010 Sep; 66(3):864-74. PubMed ID: 19912174
[TBL] [Abstract][Full Text] [Related]
13. Prevalence estimation subject to misclassification: the mis-substitution bias and some remedies.
Zhang Z; Liu C; Kim S; Liu A
Stat Med; 2014 Nov; 33(25):4482-500. PubMed ID: 25043925
[TBL] [Abstract][Full Text] [Related]
14. On the use of adjusted cross-sectional estimators of HIV incidence.
Wang R; Lagakos SW
J Acquir Immune Defic Syndr; 2009 Dec; 52(5):538-47. PubMed ID: 19881357
[TBL] [Abstract][Full Text] [Related]
15. Incidence of hepatitis B virus infection among human immunodeficiency virus-infected treatment naïve adults in Botswana.
Phinius BB; Anderson M; Bokete R; Mbangiwa T; Choga WT; Baruti K; Makhema J; Musonda R; Blackard JT; Essex M; Moyo S; Marlink R; Gaseitsiwe S
Medicine (Baltimore); 2020 Feb; 99(9):e19341. PubMed ID: 32118769
[TBL] [Abstract][Full Text] [Related]
16. A likelihood estimation of HIV incidence incorporating information on past prevalence.
Gabaitiri L; Mwambi HG; Lagakos SW; Pagano M
S Afr Stat J; 2013 Mar; 47(1):15-31. PubMed ID: 25197147
[TBL] [Abstract][Full Text] [Related]
17. Estimation of HIV-1 Incidence Using a Testing History-Based Method; Analysis From the Population-Based HIV Impact Assessment Survey Data in 12 African Countries.
Gurley SA; Stupp PW; Fellows IE; Parekh BS; Young PW; Shiraishi RW; Sullivan PS; Voetsch AC
J Acquir Immune Defic Syndr; 2023 Mar; 92(3):189-196. PubMed ID: 36730779
[TBL] [Abstract][Full Text] [Related]
18. Short Communication: Low False Recent Rate of Limiting Antigen-Avidity Assay Combined with HIV-1 RNA Data in Botswana.
Moyo S; Kotokwe KP; Mohammed T; Boleo C; Mupfumi L; Chishala S; Tsalaile L; Bussmann H; Gaseitsiwe S; Musonda R; Makhema J; Baum M; Marlink R; Engelbrecht S; Essex M; Novitsky V
AIDS Res Hum Retroviruses; 2017 Jan; 33(1):17-18. PubMed ID: 27481530
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus transmission and the role of other sexually transmitted diseases. Measures of association and study design.
Boily MC; Anderson RM
Sex Transm Dis; 1996; 23(4):312-32. PubMed ID: 8836026
[TBL] [Abstract][Full Text] [Related]
20. Implementation of Universal HIV Testing and Treatment to Reduce HIV Incidence in Botswana: the Ya Tsie Study.
Lockman S; Holme MP; Makhema J; Bachanas P; Moore J; Wirth KE; Lebelonyane R; Essex M
Curr HIV/AIDS Rep; 2020 Oct; 17(5):478-486. PubMed ID: 32797382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
